# Angiotensin-converting enzyme insertion/deletion genotype (rs4646994) association with increased risk of stroke: a case-control study in Eastern Iran

**Authors:** Setayesh MiriMoghaddam, Farzane Vafaeie, Saeede Khosravi Bizhaem, Maryam Yousefi-Roobiyat, Ebrahim Miri-Moghaddam

PMC · DOI: 10.1186/s12883-025-04503-y · BMC Neurology · 2025-11-21

## TL;DR

This study found that certain genetic variations in the ACE gene are linked to a higher risk of ischemic stroke in Eastern Iran.

## Contribution

The study identifies a significant association between the ACE I/D polymorphism and increased stroke risk in an Eastern Iranian population.

## Key findings

- The ID and DD genotypes of the ACE I/D polymorphism were more common in stroke patients than in controls.
- The D allele frequency was significantly higher in individuals with ischemic stroke compared to healthy controls.

## Abstract

Ischemic stroke (IS), the predominant subtype of stroke, represents a complex and multifactorial disease. While a genetic predisposition is hypothesized to contribute to IS risk, the influence of specific gene variants remains unclear due to inconsistent findings across studies. This study aimed to evaluate the association between the angiotensin-converting enzyme insertion/deletion (ACE, I/D) gene polymorphism and the occurrence of IS in a patient cohort from Eastern Iran.

This case-control study was conducted at the Department of Neurology, Birjand University of Medical Sciences, Eastern Iran. The study population consisted of 406 participants, including 203 individuals diagnosed with IS and 203 age- and gender-matched healthy control subjects. The diagnosis of IS was established based on a comprehensive clinical evaluation, relevant laboratory analyses, neuroimaging, specifically computed tomographyو and magnetic resonance imaging. Genomic DNAs of participants were extracted from peripheral blood samples. The ACE I/D genotypes were determined using polymerase chain reaction amplification.

The case group exhibited a higher prevalence of hypertension (71.4%), diabetes mellitus (33.5%), and dyslipidemia (36.9%), compared to the control group. Moreover, the mean systolic blood pressure was significantly elevated in the case group (146 mmHg) in comparison to the control group (123 mmHg). The ID and DD genotypes were more frequent in case subjects (46.6% and 36.8%, respectively) than in control subjects (40.2% and 32.6%, respectively). Conversely, the II genotype was more prevalent in control subjects (27.2%), compared to cases (16.6%). The D allele frequency was significantly higher in the case group (60.1%) than in the control group (52.7%) (p = 0.041, 95% CI: 0.554–0.988).

This study demonstrated a higher prevalence of the ID and DD genotypes in individuals with IS, compared to control subjects. Furthermore, the D allele frequency was significantly elevated in the IS group.

## Linked entities

- **Genes:** ACE (angiotensin I converting enzyme) [NCBI Gene 1636]
- **Diseases:** ischemic stroke (MONDO:1060198), diabetes mellitus (MONDO:0005015), dyslipidemia (MONDO:0002525)

## Full-text entities

- **Genes:** ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}, AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}
- **Diseases:** IS (MESH:D002544), diabetes mellitus (MESH:D003920), ID (MESH:C537985), hypertension (MESH:D006973), stroke (MESH:D020521), dyslipidemia (MESH:D050171)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs4646994

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12639935/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12639935/full.md

---
Source: https://tomesphere.com/paper/PMC12639935